ZYME FY 2025 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$106M+38.9% YoY

Gross Profit

$95M89.8% margin

Operating Income

-$93M-87.3% margin

Net Income

-$81M-76.6% margin

EPS (Diluted)

$-1.08

Cash Flow

Operating Cash Flow

-$33.0B

Free Cash Flow

-$33.0B

Stock-Based Comp.

$28.0B

Balance Sheet

Total Assets

$347M

Total Liabilities

$78M

Stockholders' Equity

$269M

Cash & Equivalents

$41.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$106M	$76M	+38.9%
Gross Profit	$95M	$76M	+24.7%
Operating Income	-$93M	-$137M	+32.5%
Net Income	-$81M	-$123M	+33.9%